🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can catheter-based renal denervation reduce frequency of hospitalization in patients who have resistant hypertension and heart failure with reduced ejection fraction?. elsevier.es/es-revista-hip…

Seventy years of pheochromocytomas and paragangliomas in Argentina. The FRENAR database. elsevier.es/es-revista-hip…

Assessing levels of uric acid and other cardiovascular markers in prehypertensive and hypertensive adults. elsevier.es/es-revista-hip…

Consecuencia de los trastornos hipertensivos durante el embarazo (THE) sobre la salud cardiovascular de la mujer i.mtr.cool/yajvgeaaog

Feocromocitoma como simulador de patología cardiaca. elsevier.es/es-revista-hip…

Diuretics use in the management of hypertension. elsevier.es/es-revista-hip…

Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis. elsevier.es/es-revista-hip…

Metastatic pheochromocytoma: An unusual case and its multidisciplinary management. elsevier.es/es-revista-hip…

Diseño y racional estudio observacional del Grupo Argentino Estudio Lipoproteína (a). elsevier.es/es-revista-hip…

Detección de rigidez arterial en mujeres con antecedente reciente de preeclampsia. elsevier.es/es-revista-hip…

Physicians’ perception of guideline recommendations for the treatment of resistant hypertension by renal denervation: Resistant Hypertension Working Group, Argentine Hypertension Society. elsevier.es/es-revista-hip…

Comparison of the effectiveness of aliskiren and ramipril for the management of hypertension: A systematic review and meta-analysis. elsevier.es/es-revista-hip…

Prevalence of antihypertensive medication adherence and associated factors in India: A systematic review and meta-analysis. elsevier.es/es-revista-hip…

Cardiovascular risk markers in apparently healthy young adults: Evaluation according to optimal or non-optimal office blood pressure. elsevier.es/es-revista-hip…

Cutting-edge lipid-lowering pharmacological therapies: Improving lipid control beyond statins. elsevier.es/es-revista-hip…

The reference arm – The eternal doubt. elsevier.es/es-revista-hip…

Refractory arterial hypertension. What can we offer these patients?. elsevier.es/es-revista-hip…

Refractory arterial hypertension. What can we offer these patients?. elsevier.es/es-revista-hip…

Hypertension and uric acid, uric acid and hypertension: Is hyperuricaemia a new vascular risk factor to take into account?. elsevier.es/es-revista-hip…

Cutting-edge lipid-lowering pharmacological therapies: Improving lipid control beyond statins. elsevier.es/es-revista-hip…